MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00392-024-02522-2

Медицинская библиотека · Clinical research in cardiology : official journal of the German Cardiac Society · 2024

Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?

Bellofatto Ilaria Anna, Nikolaou Panagiota Efstathia, Andreadou Ioanna, Canepa Marco, Carbone Federico, Ghigo Alessandra, Heusch Gerd, Kleinbongard Petra, Maack Christoph, Podesser Bruno K, Stamatelopoulos Kimon, Stellos Konstantinos, Vilahur Gemma, Montecucco Fabrizio, Liberale Luca

СтатьяОбзорПеревод в очереди

Аннотация

The term cardiac amyloidosis (CA) refers to the accumulation of extracellular amyloid deposits in the heart because of different conditions often affecting multiple organs including brain, kidney and liver. Notably, cardiac involvement significantly impacts prognosis of amyloidosis, with cardiac biomarkers playing a pivotal role in prognostic stratification. Therapeutic management poses a challenge due to limited response to conventional heart failure therapies, necessitating targeted approaches aimed at preventing, halting or reversing amyloid deposition. Mechanisms underlying organ damage in CA are multifactorial, involving proteotoxicity, oxidative stress, and mechanical interference. While the role of inflammation in CA remains incompletely understood, emerging evidence suggests its potential contribution to disease progression as well as its utility as a therapeutic target. This review reports on the cardiac involvement in systemic amyloidosis, its prognostic role and how to assess it. Current and emerging therapies will be critically discussed underscoring the need for further efforts aiming at elucidating CA pathophysiology. The emerging evidence suggesting the contribution of inflammation to disease progression and its prognostic role will also be reviewed possibly offering insights into novel therapeutic avenues for CA.

Для цитирования: Bellofatto Ilaria Anna, Nikolaou Panagiota Efstathia, Andreadou Ioanna, Canepa Marco, Carbone Federico, Ghigo Alessandra, Heusch Gerd, Kleinbongard Petra, Maack Christoph, Podesser Bruno K, Stamatelopoulos Kimon, Stellos Konstantinos, Vilahur Gemma, Montecucco Fabrizio, Liberale Luca. Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?. Clinical research in cardiology : official journal of the German Cardiac Society. 2024. DOI: 10.1007/s00392-024-02522-2.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.